Asthma exacerbations during the first trimester of pregnancy and congenital malformations: Revisiting the association in a large representative cohort

Thorax

Volumn 70, Issue 7, 2015, Pages 647-652

  Blais, Lucie ^a,b,c   Kettani, Fatima Zohra ^a,b   Forget, Amélie ^a,b   Beauchesne, Marie France ^a,c,d   Lemière, Catherine ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c ASTRAZENECA   (United Kingdom)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; ASTHMA; CANADA; COHORT ANALYSIS; COMORBIDITY; CONGENITAL MALFORMATION; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FIRST TRIMESTER PREGNANCY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOCIAL STATUS; SOCIAL WELFARE; ADOLESCENT; CONGENITAL ABNORMALITIES; EMBRYOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE; PREVALENCE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ASTHMA; COHORT STUDIES; CONGENITAL ABNORMALITIES; FEMALE; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; QUEBEC; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84939248944     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-206634     Document Type: Article

References (34)

1. Kwon HL, Triche EW, Belanger K, et al. The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms. Immunol Allergy Clin North Am 2006; 26: 29-62.
2. Charlton RA, Hutchison A, Davis KJ, et al. Asthma management in pregnancy. PLoS ONE 2013; 8: e60247.
3. Busse W. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment - 2004 update. J Allergy Clin Immunol 2005; 115: 34-46.
4. Firoozi F, Lemiere C, Beauchesne MF, et al. Impact of maternal asthma on perinatal outcomes: a two-stage sampling cohort study. Eur J Epidemiol 2012; 27: 205-14.
5. Bakhireva LN, Schatz M, Jones KL, et al. Asthma control during pregnancy and the risk of preterm delivery or impaired fetal growth. Ann Allergy Asthma Immunol 2008; 101: 137-43.
6. Bracken MB, Triche EW, Belanger K, et al. Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstet Gynecol 2003; 102: 739-52.
7. SteniusAarniala BSM, Hedman J, Teramo KA. Acute asthma during pregnancy. Thorax 1996; 51: 411-14.
8. Jana N, Vasishta K, Saha SC, et al. Effect of bronchial asthma on the course of pregnancy, labour and perinatal outcome. J Obstet Gynaecol 1995; 21: 227-32.
9. Schatz M, Zeiger RS, Hoffman CP, et al. Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis. Am J Respir Crit Care Med 1995; 151: 1170-4.
10. Greenberger PA, Patterson R. The outcome of pregnancy complicated by severe asthma. Allergy Proc 1988; 9: 539-43.
11. Gordon M, Niswander KR, Berendes H, et al. Fetal morbidity following potentially anoxigenic obstetric conditions. VII. Bronchial asthma. Am J Obstet Gynecol 1970; 106: 421-9.
12. Fitzsimons R, Greenberger PA, Patterson R. Outcome of pregnancy in women requiring corticosteroids for severe asthma. J Allergy Clin Immunol 1986; 78: 349-53.
13. Schatz M, Zeiger RS, Harden K, et al. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol 1997; 100: 301-6.
14. Schatz M, Dombrowski MP, Wise R, et al. The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol 2004; 113: 1040-5.
15. Blais L, Forget A. Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women. J Allergy Clin Immunol 2008; 121: 1379-84, 84.
16. Eltonsy S, Forget A, Blais L. Beta(2) - Agonists use during pregnancy and the risk of congenital malformations. Birth Defects Res A Clin Mol Teratol 2011; 91: 937-47.
17. Kallen B, Rydhstroem H, Aberg A. Asthma during pregnancy - a population based study. Eur J Epidemiol 2000; 16: 167-71.
18. Bakhireva LN, Jones KL, Schatz M, et al. Asthma medication use in pregnancy and fetal growth. J Allergy Clin Immunol 2005; 116: 503-9.
19. Tata LJ, Lewis SA, McKeever TM, et al. Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study. Thorax 2008; 63: 981-7.
20. Lin S, Herdt-Losavio M, Gensburg L, et al. Maternal asthma, asthma medication use, and the risk of congenital heart defects. Birth Defects Res A Clin Mol Teratol 2009; 85: 161-8.
21. Perlow JH, Montgomery D, Morgan MA, et al. Severity of asthma and perinatal outcome. Am J Obstet Gynecol 1992; 167(4 Pt 1): 963-7.
22. Namazy JA, Murphy VE, Powell H, et al. Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes. Eur Respir J 2013; 41: 1082-90.
23. Murphy V, Wang G, Namazy J, et al. The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis. BJOG 2013; 120: 812-22.
24. Maternal asthma and the risk of major congenital malformations: is drug insurance status an effect modifier? J Popul Ther Clin Pharmacol 2014; 21: e308-37; September 17, 2014 Supplement. 4th RQRM Annual Meeting 'New Challenges in Drug Research', Orford, Québec, Canada. Abstract #9. http://www.jptcp.com/pubmed.php?articleId=475.
25. Vilain A, Otis S, Forget A, et al. Agreement between administrative databases and medical charts for pregnancy-related variables among asthmatic women. Pharmacoepidemiol Drug Saf 2008; 17: 345-53.
26. Gershon AS, Wang C, Guan J, et al. Identifying patients with physician-diagnosed asthma in health administrative databases. Can Respir J 2009; 16: 183-8.
27. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton: Publishing Sciences Group, Inc., 1977.
28. Blais L, Berard A, Kettani FZ, et al. Validity of congenital malformation diagnostic codes recorded in Quebec's administrative databases. Pharmacoepidemiol Drug Saf 2013; 22: 881-9.
29. Zeger SL, Liang KY, Albert PS. Models for Longitudinal data - a generalized estimating equation approach. Biometrics 1988; 44: 1049-60.
30. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Pub Hlth 1989; 79: 340-9.
31. Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 2006; 61: 169-76.
32. Webster WS, Abela D. The effect of hypoxia in development. Birth Defects Res C Embryo Today 2007; 81: 215-28.
33. Rabe KF, Atienza T, Magyar P, et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006; 368: 744-53.
34. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 2002; 57: 880-4.